✨ Your Portfolio is fetched and updated from zerodha.

Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (247 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
39.30
4,28,977
68.49
1,69,794
64.85
1,47,775
19.69
1,09,635
23.30
1,08,228
23.66
1,07,576
18.68
92,231
51.62
91,853
20.54
71,619
28.05
66,512
104
63,377
56.44
60,109
38.47
58,478
66.95
56,464
41.30
42,170
42.23
38,426
36.86
37,393
82.57
37,258
44.21
33,322
33.25
28,165
31.82
27,680
26.05
22,234
66.16
22,027
107
21,576
975
21,460
-
20,497
43.77
18,895
64.42
18,486
11.75
18,291
93.11
16,680
809
16,281
26.35
14,371
22.43
14,110
40.40
14,045
31.17
13,488
40.50
12,655
20.59
12,638
93.92
12,619
56.47
11,389
20.53
11,164
25.31
11,111
41.59
9,986
48.16
9,968
63.66
9,513
114
8,820
26.93
8,798
27.65
8,114
22.04
7,942
15.47
7,913
23.88
7,600
22.93
6,688
47.56
6,596
43.90
6,586
29.61
6,329
27.68
5,965
26.90
4,985
-
4,212
-
4,125
28.68
3,797
40.38
3,618
33.44
3,397
16.30
3,303
21.63
3,293
68.57
3,277
-
3,203
15.23
3,086
146
2,759
55.11
2,758
21.77
2,586
7.78
2,293
20.97
2,288
-
2,284
-
2,278
7.09
2,260
22.59
2,247
18.14
2,103
68.07
1,985
-
1,971
-
1,825
28.96
1,648
28.43
1,607
23.96
1,599
41.33
1,451
31.29
1,281
14.21
1,249
20.50
1,231
4.79
1,191
46.82
1,181
16.55
1,141
27.82
1,138
25.18
1,068
19.26
1,008
43.13
1,000
10.89
956
12.26
936
44.08
884
19.70
847
25.06
819
24.67
816
18.64
779
-
765
-
730
35.25
637
29.26
600
37.54
599
36.13
598
21.76
567
26.27
520
36.21
484
13.61
441
34.52
418
42.42
400
19.72
391
37.14
390
40.36
388
43.70
351
29.94
347
48.15
336
27.22
320
64.42
317
-
287
47.53
277
-
274
15.39
271
27.90
270
28.03
269
81.00
268
24.26
258
25.45
250
-
226
21.30
222
26.74
221
-
219
25.05
205
59.42
204
30.26
201
-
197
17.22
190
58.97
183
8.46
183
61.14
181
13.31
181
660
171
-
167
30.45
163
10.96
153
33.64
152
11.81
148
31.52
145
14.84
143
11.30
139
52.39
137
11.56
135
-
130
15.28
123
4.95
120
24.76
120
24.60
118
13.65
117
14.37
117
16.33
110
-
109
11.63
101
26.25
98
20.66
97
169
96
379
95
-
88
72.88
88
30.07
84
11.47
82
12.84
78
11.04
75
17.41
75
97.96
72
-
72
6.47
69
15.60
67
-
64
12.98
59
11.93
59
-
58
-
58
15.76
58
3.15
56
52.95
56
139
56
7.49
54
12.46
52
15.47
52
-
51
18.19
50
210
47
58.27
44
-
43
18.38
43
17.43
43
95.31
42
2.69
41
50.70
40
-
39
-
38
7.49
36
21.66
34
16.96
33
14.14
32
-
32
-
31
-
31
7.35
30
34.74
30
350
30
-
28
6.32
26
11.68
25
7.14
24
10.69
22
25.45
22
24.21
22
-
17
35.55
16
51.21
15
106
14
-
14
-
14
-
13
20.91
13
12.96
13
-
12
37.14
12
-
11
22.53
11
871
11
9.01
9
57.28
8
-
8
89.76
7
824
7
-
6
-
5
-
5
52.36
5
-
4
-
3
45.02
3
-
2
-
1
Showing 5 247 of 247 Show More
Market Share

    Select a Metric
    • Fermentation Based API Products - Market Share (%)
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Vaccines - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Benzimidazole (%)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material